Kidney disease and muscle loss: a new study aims to uncover the link
NCT ID NCT06109662
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looks at how muscle loss (sarcopenia) affects people with chronic kidney disease (CKD) compared to healthy individuals. Researchers will measure body composition and muscle function in 80 participants. The goal is to better understand when and how muscle loss happens in CKD, which could guide future treatments to improve quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help design future trials for treatments that preserve muscle mass and improve health outcomes in people with chronic kidney disease.
- What could go wrong
- This is a small feasibility study, not a treatment trial. It may not lead directly to new therapies, and results may not apply to all kidney disease patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospitals of Derby and Burton NHS Foundation Trust
Derby, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new graft keep dialysis access working longer?
- Could muscle loss predict stroke recovery?
- Can a common gout pill shield hearts in kidney disease?
- Blood test could predict who faces rapid kidney decline in diabetes
- Can nerve changes explain Age-Related muscle loss?
- Blood test may predict kidney decline in diabetes — a large trial investigates